Cargando…

The lonidamine derivative H2-gamendazole reduces cyst formation in polycystic kidney disease

Autosomal dominant polycystic kidney disease (ADPKD) is a debilitating renal neoplastic disorder with limited treatment options. It is characterized by the formation of large fluid-filled cysts that develop from kidney tubules through abnormal cell proliferation and cyst-filling fluid secretion driv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundar, Shirin V., Zhou, Julie Xia, Magenheimer, Brenda S., Reif, Gail A., Wallace, Darren P., Georg, Gunda I., Jakkaraj, Sudhakar R., Tash, Joseph S., Yu, Alan S.L., Li, Xiaogang, Calvet, James P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Physiological Society 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9529276/ https://www.ncbi.nlm.nih.gov/pubmed/35979967 http://dx.doi.org/10.1152/ajprenal.00095.2022

Ejemplares similares

Quinomycin A reduces cyst progression in polycystic kidney disease
por: Radadiya, Priyanka S., et al.
Publicado: (2021)

Ciclopirox olamine induces ferritinophagy and reduces cyst burden in polycystic kidney disease
por: Radadiya, Priyanka S., et al.
Publicado: (2021)

Aberrant Regulation of Notch3 Signaling Pathway in Polycystic Kidney Disease
por: Idowu, Jessica, et al.
Publicado: (2018)

N-Butyldeoxygalactonojirimycin Induces Reversible Infertility in Male CD Rats
por: Gupta, Vijayalaxmi, et al.
Publicado: (2019)

Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease
por: Wallace, Darren P., et al.
Publicado: (2013)

Phase II study of lonidamine in metastatic breast cancer.
por: Pronzato, P., et al.
Publicado: (1989)

Ru(III) Complexes with Lonidamine-Modified Ligands
por: Shutkov, Ilya A., et al.
Publicado: (2021)

Inhibition of the recovery from potentially lethal damage by lonidamine.
por: Hahn, G. M., et al.
Publicado: (1984)

Inhibition of Mitochondrial Complex II by the Anticancer Agent Lonidamine
por: Guo, Lili, et al.
Publicado: (2016)

Targeting lonidamine to mitochondria mitigates lung tumorigenesis and brain metastasis
por: Cheng, Gang, et al.
Publicado: (2019)

The Potential of Lonidamine in Combination with Chemotherapy and Physical Therapy in Cancer Treatment
por: Huang, Yaxin, et al.
Publicado: (2020)

Directly targeting ASC by lonidamine alleviates inflammasome-driven diseases
por: Chen, Chen, et al.
Publicado: (2022)

Effect of lonidamine derivatives on the inhibition of transformed cell area expansion
por: Aoyama, Megumi, et al.
Publicado: (2023)

CaMK4 overexpression in polycystic kidney disease promotes mTOR-mediated cell proliferation
por: Zhang, Yan, et al.
Publicado: (2022)

Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles
por: Li, Huizhen, et al.
Publicado: (2022)

New Organometallic Ru(II) Compounds with Lonidamine Motif as Antitumor Agents
por: Shutkov, Ilya A., et al.
Publicado: (2023)

Discovering a Reversible Male Contraceptive Agent Derived from Lonidamine
por: Gong, Shengnan, et al.
Publicado: (2023)

Effects of lonidamine alone or combined with hyperthermia in some experimental cell and tumour systems.
por: Silvestrini, B., et al.
Publicado: (1983)

Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line.
por: Citro, G., et al.
Publicado: (1991)

Re-programming tumour cell metabolism to treat cancer: no lone target for lonidamine
por: Bhutia, Yangzom D., et al.
Publicado: (2016)

Effect of Differences in Metabolic Activity of Melanoma Models on Response to Lonidamine plus Doxorubicin
por: Nath, Kavindra, et al.
Publicado: (2018)

Phase II study of lonidamine in non-small cell lung cancer: final report.
por: Kokron, O., et al.
Publicado: (1990)

A phase II clinical and pharmacokinetic study of Lonidamine in patients with advanced breast cancer.
por: Mansi, J. L., et al.
Publicado: (1991)

In vitro effects of lonidamine and 6-aminonicotinamide against Echinococcus granulosussensu stricto and Echinococcus multilocularis
por: Xin, Qi, et al.
Publicado: (2020)

Lonidamine and domperidone inhibit expansion of transformed cell areas by modulating motility of surrounding nontransformed cells
por: Aoyama, Megumi, et al.
Publicado: (2022)

pH-dependent structural characteristics of lonidamine: (1)H and (13)C NMR study
por: Gupta, Pradeep Kumar, et al.
Publicado: (2023)

Glutathione Programmed Mitochondria Targeted Delivery of Lonidamine for Effective Against Triple Negative Breast Cancer
por: Wang, Zhongjie, et al.
Publicado: (2023)

The tyrosine-kinase inhibitor Nintedanib ameliorates autosomal-dominant polycystic kidney disease
por: Jamadar, Abeda, et al.
Publicado: (2021)

Stimulation of the apoptotic response as a basis for the therapeutic synergism of lonidamine and cisplatin in combination in human tumour xenografts.
por: De Cesare, M., et al.
Publicado: (1998)

Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy
por: Cervantes-Madrid, Diana, et al.
Publicado: (2015)

Mitochondrial Targeting and pH-Responsive Nanogels for Co-Delivery of Lonidamine and Paclitaxel to Conquer Drug Resistance
por: Chen, Enping, et al.
Publicado: (2021)

Therapeutic Efficacy and Safety of Paclitaxel/Lonidamine Loaded EGFR-Targeted Nanoparticles for the Treatment of Multi-Drug Resistant Cancer
por: Milane, Lara, et al.
Publicado: (2011)

Lonidamine potentiates the oncolytic efficiency of M1 virus independent of hexokinase 2 but via inhibition of antiviral immunity
por: Cai, Jing, et al.
Publicado: (2020)

LC-MS based stability-indicating method for studying the degradation of lonidamine under physical and chemical stress conditions
por: Rochani, Ankit Kanaiyalal, et al.
Publicado: (2020)

Cu(I) and Cu(II) Complexes Based on Lonidamine-Conjugated Ligands Designed to Promote Synergistic Antitumor Effects
por: Del Bello, Fabio, et al.
Publicado: (2022)

In Vitro Effect of Mitochondria-Targeted Triphenylphosphonium-Based Compounds (Honokiol, Lonidamine, and Atovaquone) on the Platelet Function and Cytotoxic Activity
por: Montecino-Garrido, Héctor, et al.
Publicado: (2022)

The energy blockers bromopyruvate and lonidamine lead GL15 glioblastoma cells to death by different p53-dependent routes
por: Davidescu, Magdalena, et al.
Publicado: (2015)

Comparison of the Lonidamine Potentiated Effect of Nitrogen Mustard Alkylating Agents on the Systemic Treatment of DB-1 Human Melanoma Xenografts in Mice
por: Nath, Kavindra, et al.
Publicado: (2016)

Proliferation-Independent Initiation of Biliary Cysts in Polycystic Liver Diseases
por: Beaudry, Jean-Bernard, et al.
Publicado: (2015)

Cyst infection in autosomal dominant polycystic kidney disease: penetration of meropenem into infected cysts
por: Hamanoue, Satoshi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_no3o0ppcshrj1uedc9ra52a89o